| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Karolinska Institute, Department of Medical Laboratory Sciences and Technology, Division of Clinical Physiology, Huddinge University Hospital, 141 86 Stockholm, Sweden; and 2 The Medical College of Wisconsin, Department of Biochemistry, Milwaukee, Wisconsin 53226
Deficiency of myoadenylate deaminase, the muscle isoform of AMP deaminase encoded by the AMPD1 gene, is a common myopathic condition associated with alterations in skeletal muscle energy metabolism. However, recent studies have demonstrated that most individuals harboring this genetic abnormality are asymptomatic. Therefore, 18 healthy subjects with different AMPD1 genotypes were studied during a 30-s Wingate test in order to evaluate the influence of this inherited defect in AMPD1 expression on skeletal muscle energy metabolism and exercise performance in the asymptomatic population. Exercise performances were similar across the AMPD1 genotypes, whereas significant differences in several descriptors of energy metabolism were observed. Normal homozygotes (NN) exhibited the highest levels of AMP deaminase activities, net ATP catabolism, and IMP accumulation, whereas intermediate values were observed in heterozygotes (MN). Conversely, mutant homozygotes (MM) had very low AMP deaminase activities and showed no significant net catabolism of ATP or IMP accumulation. Accordingly, MM also did not show any postexercise increase in plasma ammonia. Unexpectedly, MN consistently exhibited greater increases in plasma ammonia compared with NN despite the relatively lower accumulation of IMP in skeletal muscle. Moreover, time course profiles of postexercise plasma ammonia and blood lactate accumulation also differed across AMPD1 genotypes. Finally, analysis of adenosine in leftover biopsy material revealed a modest twofold increase in MN and a dramatic 25-fold increase in MM.
myoadenylate deaminase; adenine nucleotides; inosine monophosphate; adenosine; ammonia
This article has been cited by other articles:
|
|
 |
|
  D. G. Allen, G. D. Lamb, and H. Westerblad Skeletal Muscle Fatigue: Cellular Mechanisms Physiol Rev, January 1, 2008; 88(1): 287 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fischer, M. Esbjornsson, R. L. Sabina, A. Stromberg, M. Peyrard-Janvid, and B. Norman AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects J Appl Physiol, July 1, 2007; 103(1): 315 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Riksen, B. Franke, W. J.G. Oyen, G. F. Borm, P. van den Broek, O. C. Boerman, P. Smits, and G. A. Rongen Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene Eur. Heart J., May 1, 2007; 28(9): 1085 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kemp, D. Boning, R. Beneke, and N. Maassen Explaining pH Change in Exercising Muscle: Lactic acid, Proton Consumption, and Buffering vs. Strong Ion Difference Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R235 - R237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Lucia, M A Martin, J Esteve-Lanao, A F San Juan, J C Rubio, J Olivan, and J Arenas C34T mutation of the AMPD1 gene in an elite white runner. Br. J. Sports Med., March 1, 2006; 40(3): e7 - e7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Rubio, M. A. Martin, M. Rabadan, F. Gomez-Gallego, A. F. San Juan, J. M. Alonso, J. L. Chicharro, M. Perez, J. Arenas, and A. Lucia Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? J Appl Physiol, June 1, 2005; 98(6): 2108 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Hancock, E. Janssen, and R. L. Terjung Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1287 - C1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Clifford and Y. Hellsten Vasodilatory mechanisms in contracting skeletal muscle J Appl Physiol, July 1, 2004; 97(1): 393 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K Kalsi, A. H.Y Yuen, I. M Rybakowska, P. H Johnson, E. Slominska, E. J Birks, K. Kaletha, M. H Yacoub, and R. T Smolenski Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--A potential mechanism of protection in heart failure Cardiovasc Res, September 1, 2003; 59(3): 678 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rico-Sanz, T. Rankinen, D. R. Joanisse, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study Physiol Genomics, July 7, 2003; 14(2): 161 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Borza, C. V. Iancu, E. Pike, R. B. Honzatko, and H. J. Fromm Variations in the Response of Mouse Isozymes of Adenylosuccinate Synthetase to Inhibitors of Physiological Relevance J. Biol. Chem., February 21, 2003; 278(9): 6673 - 6679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Mahnke-Zizelman and R. L. Sabina N-terminal Sequence and Distal Histidine Residues Are Responsible for pH-regulated Cytoplasmic Membrane Binding of Human AMP Deaminase Isoform E J. Biol. Chem., November 1, 2002; 277(45): 42654 - 42662. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
